Fact CheckerSign in

NCT07343115Recruiting

Familial Systemic Scleroderma

Source: ClinicalTrials.gov · Last updated 15 Jan 2026

Brief summary (registry, in English)

Studying familial forms of systemic scleroderma offers several advantages: 1. To better understand the pathophysiology of a complex autoimmune disease based on "extreme" cases (familial forms); 2. To identify potential molecular markers predictive of disease progression; 3. To identify potential pathophysiological targets for developing new therapies, particularly relevant in severe and refractory forms of the disease.

Status (registry)
Recruiting
Study type
Observational
Enrollment
20 (estimated)
First submitted
6 Jan 2026
Start date
2 Sept 2025
Primary completion date
30 Sept 2026
Lead sponsor
University Hospital, Strasbourg, France
NCT number
NCT07343115

What you commit to

  • Study type: Observational
  • Planned participants: 20
  • From 2 Sept 2025 to the primary completion date, 30 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \- Subject who has expressed opposition to participating in the study

Who the study is looking for

  • Adult subjects (≥ 18 years of age)
  • Subjects diagnosed with systemic scleroderma by a clinician (including limited, diffuse, and sine scleroderma SSc, as well as overlap syndromes with myositis) and meeting at least the VEDOSS criteria: Raynaud's phenomenon + 1 other criterion from among: sausage fingers, antinuclear antibodies, scleroderma-specific antibodies (anti-centromere, anti-RNApolIII, anti-ScL70), capillaroscopic abnormalities
  • At least one first-degree relative with systemic scleroderma meeting the same criteria

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Service de Médecine interne et Immunologie clinique - CHU de Strasbourg - France
Coordinator of this site? Confirm its status
StrasbourgFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.